Loading insider details...
Beta
Latest Form 4 (Sep 18, 2026): Exercise/Conversion of 32,395 TVTX shares, $289.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 32,395 | $289.3K |
| Jun 22, 2026 | Travere Therapeutics, Inc. (TVTX) | Gift | 468 | n/a |
| May 7, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 20,000 | $448.0K |
| Apr 16, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 14,000 | n/a |
| Feb 5, 2026 | Travere Therapeutics, Inc. (TVTX) | Sale | 1,547 | $49.7K |
| Feb 4, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 28,130 | n/a |
| Jan 7, 2026 | Travere Therapeutics, Inc. (TVTX) | Sale | 2,031 | $81.6K |
| Dec 30, 2025 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 15,000 | $133.9K |
| Jul 2, 2025 | Travere Therapeutics, Inc. (TVTX) | Sale | 815 | $11.9K |
| Feb 13, 2025 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 8,000 | n/a |